[Form 4] GENERAC HOLDINGS INC Insider Trading Activity

Rhea-AI Filing Summary

International Flavors & Fragrances Inc. (NYSE: IFF) filed an 8-K on Aug 5 2025. Item 2.02 furnishes a press release (Exhibit 99.1) with Q2 2025 results and announces a live webcast on Aug 6 2025 at 9:00 a.m. ET; a recorded replay will remain on the investor‐relations site for one year.

Item 8.01 discloses a new $500 million share-repurchase program. The authorization has no expiration date. Repurchases can occur via open-market, privately negotiated or Rule 10b5-1 trades and will be funded by cash on hand and operating cash flow. The board will periodically review and may modify the program’s size or duration.

• Exhibit 99.1: Q2 2025 earnings press release (furnished, not filed).
• Exhibit 104: cover-page Inline XBRL.
• Listed securities: common stock (IFF) and 1.800% senior notes due 2026.

No other material events or financial statements were included in this report.

Positive

• $500 million share-repurchase authorization provides immediate capital-return capacity and potential EPS accretion.
• Flexible execution methods (open-market, private, 10b5-1) enhance buyback efficiency and governance oversight.

Negative

• None.

Insights

Equity Research Analyst

TL;DR: $500 m buyback adds shareholder-friendly catalyst; earnings detail not in filing.

The newly authorized $500 million repurchase (~5-6 % of market cap) signals management’s confidence in cash generation and valuation. Lack of term flexibility lets IFF pace purchases with liquidity and leverage targets, supporting EPS accretion. Because Item 2.02 only furnishes a press release, investors must review Exhibit 99.1 for core metrics and margin trajectory before revising models. Overall, the filing is modestly positive, offering capital-return upside without introducing new risks.

Corporate Governance Specialist

TL;DR: Board’s open-ended authorization increases capital-allocation flexibility.

The board empowered management to execute repurchases through multiple channels, including 10b5-1 plans, limiting blackout constraints and potential insider-trading concerns. Open-ended duration avoids recurring approvals and may improve execution timing, but periodic board reviews retain oversight. No material adverse events are disclosed, and governance practices align with peer norms.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Morgan Bennett J

(Last) (First) (Middle)

S45 W29290 HWY.59

C/O GENERAC HOLDINGS INC.

(Street)

WAUKESHA WI 53189

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
GENERAC HOLDINGS INC. [ GNRC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/01/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/01/2025		A		158	A	$190.97	31,290	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Raj Kanuru, Attorney in Fact	08/05/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

When will IFF (NYSE: IFF) discuss its Q2 2025 earnings?

Management will host a webcast on August 6 2025 at 9:00 a.m. ET.

How large is IFF's new share-repurchase program?

The board authorized up to $500 million in common-stock repurchases.

Does the buyback program have an expiration date?

No. The authorization is open-ended; the board may adjust its size or term periodically.

How will IFF fund the repurchases?

Management plans to use existing cash and operating cash flow.

Where can investors access the detailed Q2 2025 results?

Full results are in Exhibit 99.1 to the 8-K and on the company’s IR website.